• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Viral load and its relationship with the inflammatory response and clinical outcomes in hospitalization of patients with COVID-19

tetano

Editor, Senior Moderator
Front Immunol


. 2023 Jan 4;13:1060840.
doi: 10.3389/fimmu.2022.1060840. eCollection 2022.
Viral load and its relationship with the inflammatory response and clinical outcomes in hospitalization of patients with COVID-19


Mauricio Kuri-Ayache[SUP] 1 [/SUP], Andrea Rivera-Cavazos[SUP] 2 3 [/SUP], María Fátima Pérez-Castillo[SUP] 2 3 [/SUP], Juan Enrique Santos-Macías[SUP] 2 4 [/SUP], Arnulfo González-Cantú[SUP] 3 5 [/SUP], José Antonio Luviano-García[SUP] 2 4 [/SUP], Diego Jaime-Villalón[SUP] 6 [/SUP], Dalia Gutierrez-González[SUP] 3 [/SUP], Maria Elena Romero-Ibarguengoitia[SUP] 2 3 [/SUP]



Affiliations

Abstract

Background: The values of viral load in COVID-19 disease have gained relevance, seeking to understand its prognostic value and its behavior in the course of the disease, although there have been no conclusive results. In this study we sought to analyze serum viral load as a predictor of clinical outcome of the disease, as well as its association with inflammatory markers.
Methods: An observational and retrospective study in a private hospital in North Mexico, patients with SARS-COV-2 infection confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) were followed through clinical outcome, viral load measurement, quantification of inflammatory markers and lymphocyte subpopulations. For the analysis, multiple regression models were performed. Results: We studied 105 patients [47 (SD 1.46) years old, 68.6% men]. After analysis with multiple regression models, there was an association between viral load at admission and vaccination schedule (β-value=-0.279, p= 0.007), age (β-value= 0.010, p = 0.050), mechanical ventilation (β-value= 0.872, p = 0.007), lactate dehydrogenase (β-value= 1.712, p= 0.004), D-dimer values at admission (β-value= 0.847, p= 0.013) and subpopulation of B lymphocytes at admission (β-value= -0.527, p= 0.042). There was no association with days of hospitalization, use of nasal prongs or high flux mask. Peak viral load (10 days after symptoms onset) was associated with peak IL-6 (β-value= 0.470, p= 0.011). Peak viral load matched with peak procalcitonin and minimal lymphocyte values. C-reactive protein peak was before the peak of viral load. The minimum value viral load was documented on day 12 after symptom onset; it matched with the minimum values of IL-6 and ferritin, and the peak of D-dimer.
Conclusions: SARS-COV-2 admission viral load is associated with vaccination status, mechanical ventilation, and different inflammatory markers.

Keywords: D dimer; SARS-Cov-2; coronavirus infection; interleukein-6; lactate dehidrogenase; lymphocyte population; viral load.
 
Back
Top Bottom